Latest Articles
Studying Endometrial Cancer in Black Women - news.med.miami.edu
Studying Endometrial Cancer in Black Women news.med.miami.edu
Published: March 18, 2024, 7 a.m.
Dr Marth on Frontline Lenvatinib Plus Pembrolizumab in Endometrial Cancer - OncLive
Dr Marth on Frontline Lenvatinib Plus Pembrolizumab in Endometrial Cancer OncLive
Published: March 18, 2024, 7 a.m.
GSK Builds Case for Broader Jemperli Label in Endometrial Cancer with Phase III Data - BioSpace
GSK Builds Case for Broader Jemperli Label in Endometrial Cancer with Phase III Data BioSpace
Published: March 18, 2024, 7 a.m.
AstraZeneca, GSK make case for broad immunotherapy uses in endometrial cancer. But questions remain - FiercePharma
AstraZeneca, GSK make case for broad immunotherapy uses in endometrial cancer. But questions remain FiercePharma
Published: March 18, 2024, 7 a.m.
“Unprecedented OS Benefit” Seen in Advanced, Recurrent Endometrial Cancer - Oncology News Central
“Unprecedented OS Benefit” Seen in Advanced, Recurrent Endometrial Cancer Oncology News Central
Published: March 17, 2024, 7 a.m.
RUBY Part 2 trial results: Potentially practice changing results in advanced/recurrent endometrial cancer - EurekAlert
RUBY Part 2 trial results: Potentially practice changing results in advanced/recurrent endometrial cancer EurekAlert
Published: March 16, 2024, 7 a.m.
Research reveals link between environmental pollutants and endometrial cancer - News-Medical.Net
Research reveals link between environmental pollutants and endometrial cancer News-Medical.Net
Published: March 14, 2024, 7 a.m.
Dostarlimab given NICE go-ahead in first-line combination treatment for endometrial cancer - Hospital Healthcare
Dostarlimab given NICE go-ahead in first-line combination treatment for endometrial cancer Hospital Healthcare
Published: March 14, 2024, 7 a.m.
A comprehensive analysis and experimental validation of TK1 in uterine corpus endometrial carcinoma - Nature.com
A comprehensive analysis and experimental validation of TK1 in uterine corpus endometrial carcinoma Nature.com
Published: March 13, 2024, 7 a.m.
Melatonin: Current evidence on protective and therapeutic roles in gynecological diseases.
Melatonin, a potent antioxidant and free radical scavenger, has been demonstrated to be effective in gynecological conditions and female reproductive cancers. This review consolidates the accumulating evidence on melatonin's multifaceted …
Published: March 11, 2024, midnight
Link copied to clipboard!